Clinical Trials Logo

Filter by:
NCT ID: NCT05933408 Completed - Clinical trials for Colorectal (Colon or Rectal) Cancer

TREM-1 - a New Marker of Serious Infectious Complications in Colorectal Surgery?

Start date: November 1, 2018
Phase:
Study type: Observational

The aim of this study is to investigate the potential use of soluble TREM-1 (sTREM-1) to predict serious infectious complications in patients undergoing laparoscopic colorectal surgery. Patients with colon or rectal cancer, who underwent elective laparoscopic colorectal cancer surgery between November 2018 and February 2020 were included into study. Blood samples for the TREM-1 protein assay were collected from each patient four times: preoperatively and on three following postoperative days (PODs). Patients with infectious complications who formed group 1, were matched 1:1 with patients without complications (group 2). Case-matched analysis was performed by selecting patients for the control group from the group of patients paired by age, ASA scale, stage of cancer and type of surgery.

NCT ID: NCT05930652 Completed - Clinical trials for Stress, Psychological

Cumulative Stress and Mental Health in Young Adults

Start date: April 12, 2023
Phase:
Study type: Observational

The goal of this observational study is to learn about the needs of young adults - "policrisis generation", exposed to cumulative stress during 2020-2023, in terms of quality of mental health, the psychosocial resources, protective factors for cumulative stress effect, and the standards for effective prevention. The main questions to be answered are: - How does cumulative stress affect young adults? - Is there a specific cumulative stress syndrome that can be described? - What are the risk and the protective factors for cumulative stress? - How does the "policrisis generation" deal with the cumulative stress they have been exposed to? Participants will complete psychological questionnaires

NCT ID: NCT05930522 Completed - Clinical trials for Psychomotor Development Impaired

Psychomotor Performance of Preterm Infants

Start date: October 1, 2018
Phase:
Study type: Observational

The first part involved 120 children in grades II and III of elementary schools. From this group, children were qualified for the second part of the study - 35 randomly selected children born on time (BoT) and 35 children born before 35 weeks of pregnancy (PB). EUROFIT tests, Vienna Tests and postural stability tests were carried out in both groups.

NCT ID: NCT05920746 Completed - Clinical trials for Rheumatoid Arthritis

Treatment of Rheumatoid Hand With Magnetotherapy

Start date: March 1, 2021
Phase: N/A
Study type: Interventional

Brief Summary: Participants with rheumatoid arthritis with recommendation to physiotherapy. Created 2 study groups: 1. Kinesiotherapy with static magnetic field 2. Kinesiotherapy with low-frequency pulsed magnetic field Pulsed magnetic field give better effects then static magnetic field.

NCT ID: NCT05915728 Completed - Clinical trials for Contrast Enhancement in Magnetic Resonance Imaging

A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Any Known or Suspected Problems of the Body (Except Brain or Spinal Cord-related Problems)

Quanti OBR
Start date: July 24, 2023
Phase: Phase 3
Study type: Interventional

Researchers are looking for a better way to help people with any known or suspected problems (except brain or spinal cord-related problems) scheduled for a "contrast-enhanced" Magnetic Resonance Imaging (MRI). MRI is used by doctors to create detailed images of the inside of the body to identify health problems. Sometimes doctors need to inject contrast agent into a patient's vein to perform a so called "contrast-enhanced" MRI (CE-MRI). Such CE-MRI examinations may support doctors to identify certain health problems or improve the evaluation. The contrast agents commonly used in MRI are gadolinium-based contrast agents (GBCAs). GBCAs contain a "rare earth" element called gadolinium (Gd). Gadoquatrane is a new contrast agent under development with a lower amount of Gd needed per CE-MRI. The main purpose of this study is to learn whether CE-MRI scans with gadoquatrane work better than MRI scans without the use of a contrast agent (GBCA). The researchers will compare the ability to detect known or suspected problems (except brain or spinal cord-related problems) with gadoquatrane-MRI scans to plain-MRI scans without the use of a contrast agent. The participants will undergo 2 MRI scans, one with gadoquatrane and one with currently used GBCA. Both contrast agents will be injected into the vein. Each participant will be in the study for between 6 and 42 days with up to 7 doctor visits. At the start or during the study, the doctors and their study team will: - take blood and urine samples - do physical examinations - check blood pressure and heart rate - review the MRI scans obtained in the study and decide on the diagnosis - ask the participants questions about how they are feeling and what adverse events they are having. An adverse event is any medical problem that a participant has during a study. Doctors keep track of all adverse events, irrespective if they think it is related or not to the study treatments.

NCT ID: NCT05896449 Completed - Glioma, Malignant Clinical Trials

Predictive Values of Preoperative [68Ga]Ga-PSMA-11 PET/CT in Patients With Suspected Brain Tumours of Glial Origin

Start date: June 1, 2020
Phase: N/A
Study type: Interventional

The aim of this study was to analyse usefulness of [68Ga]Ga-PSMA-11 PET/CT scans in preoperative differentiation between HGG and LGG in patients with suspicion of a tumor of glial origin in previously performed imaging examinations. The PET/CT scan will be compared with postoperative histopathological results and with additional immunohistochemical staining for PSMA expression.

NCT ID: NCT05889832 Completed - Clinical trials for Heart Rate Variability

Contactless Measurement of Heart Rate, Heart Rate Variability and Breathing Rate Using Remote Photoplethysmography

Start date: April 26, 2023
Phase: N/A
Study type: Interventional

The purpose of this study it to evaluate the accuracy of heart rate, heart rate variability and breathing rate measurement with the use of Shen.AI Vitals software developed by MX Labs.

NCT ID: NCT05887765 Completed - Cerebral Palsy Clinical Trials

Effect of Systematic Dexamethasone on the Duration of Popliteal Nerve Block for Anesthesia After Pediatric Ankle Surgery

Start date: October 17, 2023
Phase: Phase 4
Study type: Interventional

Effect of systematic dexamethasone on the duration of popliteal nerve block after pediatric ankle/foot surgery

NCT ID: NCT05882136 Completed - Porphyrias, Hepatic Clinical Trials

Acute Intermittent Porphyria Related Abnormalities in Cardiovascular System

AIPRACUS
Start date: April 5, 2019
Phase:
Study type: Observational

This study aims to assess the changes in the cardiovascular system in patients with acute intermittent porphyria (AIP).

NCT ID: NCT05876949 Completed - Clinical trials for This is a Phase I Study Conducted in Healthy Volunteers

AVT03 With Xgeva in Healthy Male Subjects

Start date: July 21, 2023
Phase: Phase 1
Study type: Interventional

This study has been designed as a randomized, double-blind, parallel-group study and in healthy adult male subjects of age 28 years to 55 years old. The study will assess the PK, safety and tolerability of AVT03 compared to US-Xgeva when administered as a single 120 mg SC dose